Fresenius Medical Care Ventures GmbH

About The Fund

Fresenius Medical Care Ventures GmbH (FMCV) is an investment firm focused on nurturing innovation within the healthcare industry. As a corporate venture capital fund of Fresenius Medical Care, they invest in start-ups and early-stage companies that show potential for significant impact in the healthcare sector, with a special emphasis on medical devices, pharmaceuticals, digital healthcare, and healthcare services. FMCV seeks out opportunities that align with its strategic priorities, aiming to create partnerships that can expedite the journey of bringing new technologies and therapy approaches to market. They have a global orientation and are open to investing in companies at various stages, from seed to later stages, judged by how these fit with the company's corporate objectives. FMCV actively involves itself in the operational and strategic development of its portfolio companies, leveraging Fresenius Medical Care's extensive expertise and resources to achieve shared goals. Their portfolio includes a range of innovative healthcare solutions, from a non-emergency medical transport network through SafeRide Health to advanced patient monitoring technologies such as BioIntelliSense. Other investments include eGenesis, focusing on organ transplant solutions, and Modulim, which advances microvascular health monitoring. True to the commitment to improving patient lives, the portfolio also includes therapeutic advancements for conditions affecting the kidneys and broader health challenges. The team at FMCV is constituted of experienced professionals like Dr. Olaf Schermeier, Mr. Albert Wiegman, and Dr. Andreas Wuepper among others, all of whom bring vast expertise from the health care and investment sectors to the table. Located in Bad Homburg, Germany, FMCV extends Fresenius Medical Care's mission of providing a future worth living for patients through strategic investments and fostering innovations in the healthcare landscape.